SiriusPoint Ltd 8K

SiriusPoint Ltd. furnished a Q2 2026 investor presentation outlining strong underwriting and investment results, capital strength, shareholder capital returns, and its strategy to sustain 12–15% ROE across the cycle.

SiriusPoint Ltd. furnished an investor presentation dated July 29, 2026 in connection with its second quarter and half-year 2026 results, highlighting upgraded financial strength ratings to A from S&P, AM Best and Fitch, Q2 2026 operating ROE of 13.8% and HY 2026 operating ROE of 14.7%, a Q2 2026 core combined ratio of 91.4% and HY 2026 core combined ratio of 90.1%, growth in gross written premium particularly in its Insurance & Services segment, continued runoff of non-core portfolios supported by loss portfolio transfers, strong capital and liquidity metrics including an estimated 239% Bermuda Solvency Capital Ratio and reduced leverage, active capital management with $295 million returned to shareholders year-to-date (including preference share redemptions and share repurchases), and the contribution and perceived undervaluation of its MGA and Accident & Health platforms, while providing extensive non-GAAP reconciliations and forward-looking commentary on its strategy to deliver a 12–15% ROE across the cycle.

Filing Facts

CIK

1576018

Ticker

-

Form

8K

Source Type

sec

Accession

0001576018-26-000084

Alert Tier

5